Emergence and Recovery of Ceftazidime-avibactam Resistance inblaKPC-33-HarboringKlebsiella pneumoniaeSequence Type 11 Isolates in China
Authors:
- 15 November 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 71 (Supplement) , S436-S439
Abstract
This is the first report of ceftazidime–avibactam resistance caused by the blaKPC-33 mutation through the D179Y variant during the treatment of blaKPC-2-positive Klebsiella pneumoniae-related infections in China. The blaKPC-33-containing K. pneumoniae was susceptible to meropenem–vaborbactam, cefepime–zidebactam, tigecycline, and polymyxin B. The blaKPC-33 gene was located on a 77 551-bp transformable plasmid harboring qnrS1 and blaLAP-2. Detecting blaKPC-33-positive K. pneumoniae clinical strains is important for infection control.Keywords
Funding Information
- National Natural Science Foundation of China (81871690, 81902101, 81861138051)
- National Mega-project for Innovative Drugs (2019ZX09721001-006-004)
- China Antimicrobial Surveillance Network (WI207259)
This publication has 15 references indexed in Scilit:
- Phenotypic and Genotypic Characterization of Carbapenem-resistantEnterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012–2016)Clinical Infectious Diseases, 2018
- Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in bla KPC-2 -Harboring Klebsiella pneumoniae Sequence Type 307 IsolatesAntimicrobial Agents and Chemotherapy, 2018
- Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux ActivityAntimicrobial Agents and Chemotherapy, 2017
- Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in Klebsiella pneumoniae Carbapenemase-Producing K pneumoniae: A Case Report and Review of LiteratureOpen Forum Infectious Diseases, 2017
- In Vitro Selection of Meropenem Resistance among Ceftazidime-Avibactam-Resistant, Meropenem-Susceptible Klebsiella pneumoniae Isolates with Variant KPC-3 CarbapenemasesAntimicrobial Agents and Chemotherapy, 2017
- Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor CombinationsClinical Infectious Diseases, 2016
- Commentary: Continuing Challenges for the Clinical Laboratory for Detection of Carbapenem-Resistant EnterobacteriaceaeJournal of Clinical Microbiology, 2015
- Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loopJournal of Antimicrobial Chemotherapy, 2015
- Contribution of β-Lactamases and Porin Proteins OmpK35 and OmpK36 to Carbapenem Resistance in Clinical Isolates of KPC-2-Producing Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2014
- Exploring the Role of a Conserved Class A Residue in the Ω-Loop of KPC-2 β-LactamaseJournal of Biological Chemistry, 2012